Request Demo
Last update 18 Jul 2025
Amgen Technology (Ireland) Unlimited Co.
Last update 18 Jul 2025
Overview
Related
CTR20190717
一项在复发性多发性骨髓瘤患者中比较卡非佐米联合地塞米松与硼替佐米联合地塞米松的随机、开放标签的3期研究
[Translation] A randomized, open-label, phase 3 study comparing carfilzomib plus dexamethasone with bortezomib plus dexamethasone in patients with relapsed multiple myeloma
100 Clinical Results associated with Amgen Technology (Ireland) Unlimited Co.
Login to view more data
Login to view more data
100 Deals associated with Amgen Technology (Ireland) Unlimited Co.
Login to view more data
100 Translational Medicine associated with Amgen Technology (Ireland) Unlimited Co.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 15 Aug 2025
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free